2019 Volume 55 Issue 5 Pages 939-944
Purpose: We analyzed the efficacy of the new antiseptic solution “Olanedine® antiseptic applicator” in pediatric surgery, because to the best of our knowledge, there have been no reports about it.
Methods: Patients who were scheduled to receive surgery for inguinal hernia, undescended testis, and umbilical hernia were divided into two groups on the basis of the antiseptic used (P-Group: treated with povidone-iodine; O-Group: treated with Olanedine® antiseptic applicator). Preoperative time (from intubation to the start of surgery), incidence of infection, incidence of skin lesions, and cost were compared between the two groups.
Results: Surgeries were performed in 294 patients (P-Group: 130 patients; O-Group: 164 patients). There were no statistically significant differences in sex distribution (P-Group: 42 women, 88 men; O-Group: 45 women, 119 men), mean age (P-Group: 39.7 months; O-Group: 40.8 months), underlying disease, and incidence of infections. The average preoperative time was significantly shorter in the O-group (10 min) than in the P-group (13 min). Furthermore, the incidence of postoperative skin lesions was significantly lower in the O-Group (0 patients) than in the P-group (6 patients). The cost of treatment was lower for the O-Group than for the P-Group.
Conclusions: The new antiseptic solution Olanedine® antiseptic applicator is expected to reduce the preoperative time, the incidence of infections, and the cost of pediatric surgery.
